These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33905310)

  • 1. Review of the mechanism underlying mefloquine-induced neurotoxicity.
    Martins AC; Paoliello MMB; Docea AO; Santamaria A; Tinkov AA; Skalny AV; Aschner M
    Crit Rev Toxicol; 2021 Mar; 51(3):209-216. PubMed ID: 33905310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antimalarial potential of 4-quinolinecarbinolamines may be limited due to neurotoxicity and cross-resistance in mefloquine-resistant Plasmodium falciparum strains.
    Dow GS; Koenig ML; Wolf L; Gerena L; Lopez-Sanchez M; Hudson TH; Bhattacharjee AK
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2624-32. PubMed ID: 15215119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mefloquine neurotoxicity is mediated by non-receptor tyrosine kinase.
    Milatovic D; Jenkins JW; Hood JE; Yu Y; Rongzhu L; Aschner M
    Neurotoxicology; 2011 Oct; 32(5):578-85. PubMed ID: 21241737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mefloquine binding to human acyl-CoA binding protein leads to redox stress-mediated apoptotic death of human neuroblastoma cells.
    Kumar A; Ghosh DK; Ranjan A
    Neurotoxicology; 2020 Mar; 77():169-180. PubMed ID: 31987860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small-fish model for behavioral-toxicological screening of new antimalarial drugs: a comparison between erythro- and threo-mefloquine.
    Maaswinkel H; Zhu L; Weng W
    BMC Res Notes; 2015 Apr; 8():122. PubMed ID: 25886204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular targets of mefloquine.
    Ghosh DK; Kumar A; Ranjan A
    Toxicology; 2021 Dec; 464():152995. PubMed ID: 34678321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mefloquine neurotoxicity: a literature review.
    Toovey S
    Travel Med Infect Dis; 2009 Jan; 7(1):2-6. PubMed ID: 19174293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons.
    Hood JE; Jenkins JW; Milatovic D; Rongzhu L; Aschner M
    Neurotoxicology; 2010 Sep; 31(5):518-23. PubMed ID: 20562019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric side effects of mefloquine: applications to forensic psychiatry.
    Ritchie EC; Block J; Nevin RL
    J Am Acad Psychiatry Law; 2013; 41(2):224-35. PubMed ID: 23771936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mefloquine for malaria chemoprophylaxis 1992-1998: a review.
    Schlagenhauf P
    J Travel Med; 1999 Jun; 6(2):122-33. PubMed ID: 10381965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.
    Palmer KJ; Holliday SM; Brogden RN
    Drugs; 1993 Mar; 45(3):430-75. PubMed ID: 7682911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mood disorder after malaria prophylaxis with mefloquine (two case reports)].
    Oueriagli Nabih F; Touhami M; Laffinti A; Abilkacem L
    Encephale; 2011 Oct; 37(5):393-6. PubMed ID: 22032283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limbic encephalopathy and central vestibulopathy caused by mefloquine: a case report.
    Nevin RL
    Travel Med Infect Dis; 2012 May; 10(3):144-51. PubMed ID: 22494697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria.
    Karbwang J; Bangchang KN; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
    Lancet; 1992 Nov; 340(8830):1245-8. PubMed ID: 1359318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
    McArdle JJ; Sellin LC; Coakley KM; Potian JG; Quinones-Lopez MC; Rosenfeld CA; Sultatos LG; Hognason K
    Neuropharmacology; 2005 Dec; 49(8):1132-9. PubMed ID: 16081111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the developmental toxicity of combined artesunate and mefloquine antimalarial drugs on rats.
    Boareto AC; Müller JC; de Araujo SL; Lourenço AC; Lourenço EL; Gomes C; Minatovicz B; Lombardi N; Paumgartten FR; Dalsenter PR
    Reprod Toxicol; 2012 Dec; 34(4):658-64. PubMed ID: 23069110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of mefloquine administration during early pregnancy on rat embryonic development.
    El-Dakdoky MH
    Toxicol Mech Methods; 2015 Feb; 25(2):105-12. PubMed ID: 25406758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side effects of and compliance with malaria prophylaxis in children.
    Albright TA; Binns HJ; Katz BZ
    J Travel Med; 2002; 9(6):289-92. PubMed ID: 12962582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of alkylaminoquinolinyl methanols as new antimalarial drugs.
    Dow GS; Heady TN; Bhattacharjee AK; Caridha D; Gerena L; Gettayacamin M; Lanteri CA; Obaldia N; Roncal N; Shearer T; Smith PL; Tungtaeng A; Wolf L; Cabezas M; Yourick D; Smith KS
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4132-43. PubMed ID: 16966402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mefloquine-associated dizziness, diplopia, and central serous chorioretinopathy: a case report.
    Jain M; Nevin RL; Ahmed I
    J Med Case Rep; 2016 Oct; 10(1):305. PubMed ID: 27799060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.